文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

面向快速高效免模拟放疗:基于诊断MRI参考规划的MR-Linac前列腺自适应放疗

Towards rapid and efficient simulation-free radiotherapy: MR guided adaptive prostate radiotherapy on the MR-Linac using diagnostic MRI reference planning.
PubMed 文献 · Radiother Oncol · 2025-07-19

该规划研究提出并评估了MR-Linac上前列腺癌在线自适应放疗的免模拟预处理工作流,利用既往诊断MRI生成参考治疗计划而无需临床医生输入,并模拟自适应计划与传统工作流比较。结果显示87.5%患者诊断扫描适用,模拟计划靶区剂量和适形性临床可接受,满足所有强制临床目标,OAR剂量和计划可交付性无劣势,合成CT精度高(2mm/2% gamma均>98.9%)。

要点

  • 利用诊断MRI可生成前列腺MR-Linac参考计划,无需模拟和临床医生输入。
  • 模拟自适应计划靶区剂量与适形性临床可接受,OAR剂量无劣势。
  • 合成CT精度高,2mm/2% gamma通过率均高于98.9%。

核心结论

  • 非放疗专用诊断MRI可用于MR-Linac上前列腺参考计划制定,生成的模拟自适应计划与放疗模拟参考计划临床等效。

研究设计与样本

  • 规划研究,回顾性评估HERMES试验中接受36.25 Gy分5次治疗的全部患者是否适合免模拟参考计划。
  • 利用现有诊断MRI(T1w和T2w)创建参考图像,自动分割靶区和OAR参考结构而无需临床医生输入。
  • 使用现有临床治疗图像和结构集模拟在线计划自适应,并与现有临床计划比较,同时评估合成CT精度。

主要发现

  • 87.5%患者具有适用的诊断扫描。
  • 参考图像和治疗计划成功创建,模拟在线治疗计划在靶区剂量和适形性方面临床可接受,满足所有强制临床目标,OAR剂量或计划可交付性无劣势。
  • 合成CT方法精度高,2mm/2%的gamma结果均高于98.9%。

关键数值与推荐

  • 模拟在线治疗计划满足所有强制临床目标,靶区剂量和适形性临床可接受。
  • 合成CT的gamma通过率在2mm/2%标准下均高于98.9%。

临床怎么用

  • 可考虑利用既往诊断MRI为前列腺癌MR-Linac在线自适应放疗创建免模拟参考计划,可能节省数周流程时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Simulation-free radiotherapy offers improved efficiency for adaptive treatments. This planning study presents a simulation-free pre-treatment workflow for prostate cancer online adaptive radiotherapy on a MR-Linac. Previously acquired diagnostic MR images are used to create a reference treatment plan without clinician input, and adapted plans are then simulated, and compared with those from the traditional workflow. MATERIALS AND METHODS: All patients treated with 36.25 Gy in 5-fractions within the HERMES trial were retrospectively assessed for eligibility of simulation-free reference planning. If eligible, reference images were created from existing diagnostic MRI (T1w and T2w) to enable MR-only reference treatment planning. Target and OAR reference structures were autosegmented without clinician input. Online plan adaptation was simulated using existing clinical treatment images and structure sets. Adapted plans were compared with existing clinical plans, and synthetic CT accuracy assessed. RESULTS: 87.5 % of patients had suitable diagnostic scans. Reference images and treatment plans were successfully created. Online treatment plans were simulated and were clinically acceptable for target dose and conformality, meeting all mandatory clinical goals with no detriment to OAR dose or plan deliverability. Accuracy of the synthetic CT approach was high with gamma results at 2mm/2% all above 98.9 %. CONCLUSION: This study has shown that non radiotherapy-dedicated diagnostic MRI can be used for reference prostate planning on the MR-Linac, generating clinically equivalent adapted plans when compared to those originating from radiotherapy-simulation reference plans. This potentially saves multiple weeks in the pathway, improving radiotherapy efficiency and patient experience.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chick J, Casey F, Cooper S, et al. Towards rapid and efficient simulation-free radiotherapy: MR guided adaptive prostate radiotherapy on the MR-Linac using diagnostic MRI reference planning. Radiother Oncol. 2025. PMID: 40692080. doi:10.1016/j.radonc.2025.111053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。